Clinical Trial Update: Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating apatinib in combination with Abraxane and carboplatin or cisplatin as first-line therapy for epithelial ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Apatinib (apatinib)
• CARBOPLATIN (Carboplatin)
• CISPLATIN (cisplatin)

Snippet

Sponsor: Zhongshan Hospital Xiamen University | Conditions: Ovarian Cancer | Phase 2 | Status: UNKNOWN